EP4405046 - POLYACRYLAMIDE HYDROGEL FOR USE IN THE TREATMENT AND/OR PREVENTION OF OSTEOARTHRITIS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 27.06.2024 Database last updated on 12.10.2024 | |
Former | The international publication has been made Status updated on 25.03.2023 | ||
Former | unknown Status updated on 07.10.2022 | Most recent event Tooltip | 27.09.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Contura International A/S Sydmarken 23 2860 Soborg / DK | [2024/31] | Inventor(s) | 01 /
ANKORINA-STARK, Ieva 2990 Nivå / DK | [2024/31] | Representative(s) | Plougmann Vingtoft a/s Strandvejen 70 2900 Hellerup / DK | [2024/31] | Application number, filing date | 22777632.5 | 20.09.2022 | [2024/31] | WO2022EP76016 | Priority number, date | EP20210197730 | 20.09.2021 Original published format: EP 21197730 | [2024/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023041790 | Date: | 23.03.2023 | Language: | EN | [2023/12] | Type: | A1 Application with search report | No.: | EP4405046 | Date: | 31.07.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.03.2023 takes the place of the publication of the European patent application. | [2024/31] | Search report(s) | International search report - published on: | EP | 23.03.2023 | Classification | IPC: | A61P19/02, A61K31/78 | [2024/31] | CPC: |
A61K31/78 (EP,IL,KR);
A61L27/16 (KR);
A61L27/52 (KR);
C08F220/56 (EP,IL,KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/31] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | POLYACRYLAMIDHYDROGEL ZUR VERWENDUNG BEI DER BEHANDLUNG UND/ODER PRÄVENTION VON OSTEOARTHRITIS | [2024/31] | English: | POLYACRYLAMIDE HYDROGEL FOR USE IN THE TREATMENT AND/OR PREVENTION OF OSTEOARTHRITIS | [2024/31] | French: | HYDROGEL DE POLYACRYLAMIDE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT ET/OU LA PRÉVENTION DE L'ARTHROSE | [2024/31] | Entry into regional phase | 25.03.2024 | National basic fee paid | 25.03.2024 | Designation fee(s) paid | 25.03.2024 | Examination fee paid | Examination procedure | 14.07.2023 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 25.03.2024 | Examination requested [2024/31] | 25.03.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 25.09.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO2017167348 (CONTURA INT AS [DK]); | by applicant | WO0216453 | WO2012123385 |